Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6738494 | 7401883 | I | 6738494-9 | 20100305 | 20100511 | 20100520 | EXP | TPA2010A01088 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | 59 | YR | F | N | 223 | LBS | 20100519 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6738494 | 1013740261 | PS | ACTOS | 1 | ORAL | 30 MG, 1 IN 1 D, PER ORAL | Y | D | 21073 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6738494 | 1013740261 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6738494 | OT |
| 6738494 | RI |
Reactions reported
| Event ID | PT |
|---|---|
| 6738494 | COUGH |
| 6738494 | FALL |
| 6738494 | MUSCULAR WEAKNESS |
| 6738494 | OROPHARYNGEAL PAIN |
| 6738494 | RHINORRHOEA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6738494 | CSM |
| 6738494 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6738494 | 1013740261 | 20100302 | 20100309 |